Table 2.

The clinical parameters of the training set and the test set are shown in

Variable	Training set (n = 124)	Test set (n = 82)	P
Age(years)	50.00 (43.00–56.00)	52.50 (46.00–59.00)	0.114
BMI	22.69 (20.25–25.19)	22.03 (19.92–24.20)	0.161
Maximum diameter of tumor (mm)	80.00 (53.00–105.00)	94.50 (57.00–115.00)	0.124
CEA (ng/ml)	1.70 (0.90–2.60)	1.71 (1.12–2.89)	0.431
CA125 (IU/ml)	692.00 (164.50–1384.6)	561.70 (143.50–1296.5)	0.431
CA153 (IU /ml)	34.54 (15.50–72.20)	36.35 (16.36–95.05)	0.776
CA199 (IU/ml)	12.28 (4.32–108.44)	17.32 (4.24–73.34)	0.694
SCC (ng/L)	0.70 (0.50–1.10)	0.60 (0.50–1.20)	0.830
HCG (mIU/ml)	0.56 (0.10–1.88)	1.02 (0.10–2.14)	0.149
HE4	172.70 (76.10–498.50)	159.60 (73.20–519.90)	0.602
AFP(ng/ml)	2.34 (1.79–3.27)	2.43 (1.58–3.35)	0.983
pre ROMA	69.33 (19.41–96.68)	60.97 (18.34–97.53)	0.630
post ROMA	79.61 (46.90–99.96)	76.96 (45.97–99.84)	0.502
Menopausal.state #			0.993
NO	53 (42.75)	35 (42.68)
YES	71 (57.25)	47 (57.32)
Ascites #			0.309
NO	45 (36.29)	36 (43.90)
YES	79 (63.71)	46 (56.10)
Figo stage #			0.106
I-II	50 (40.32)	24 (29.27)
III-IV	74 (59.68)	58 (70.73)

^#The counting data

Pre ROMA, Premenopausal ROMA; Post ROMA, Postmenopausal ROMA